English | Español
Press release submission | Apr 28, 2018

PFIZER: MYLOTARG™ Approved In The EU For The Treatment Of Previously Untreated, De Novo, CD33-positive Acute Myeloid Leukemia In Combination With Chemotherapy
Press release submission | Apr 28, 2018

TEXAS MEDICAL CENTER: A New Era for the Texas Medical Center
Press release submission | Apr 28, 2018

CLEVELAND CLINIC: New MS Guidelines Call for Treatment Sooner
Press release submission | Apr 28, 2018

MASSACHUSETTS GENERAL HOSPITAL: Imaging may allow safe tPA treatment of patients with unwitnessed strokes
Press release submission | Apr 28, 2018

PFIZER: Pfizer Provides Update on Proposed Trastuzumab Biosimilar
Press release submission | Apr 27, 2018

MASSACHUSETTS GENERAL HOSPITAL: Study identifies overdose risk factors in youth with substance use disorders
Press release submission | Apr 27, 2018

TEXAS MEDICAL CENTER: Regaining a Sense of Smell
Press release submission | Apr 27, 2018

CLEVELAND CLINIC:Research Links Proper Sleep to Better Dietary Choices

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jun 23, 2025

PhRMA says patients in the U.S. face higher prescription costs due to 340B program
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’